Nitrovasodilator-induced inhibition of LTB4 release from human PMN may be mediated by cyclic GMP.

P. Ney, H. Schröder, K. Schrör

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

This study investigates the action of nitrovasodilators on f-metleu-phe (FMLP)-stimulated LTB4 release and intracellular cyclic nucleotide levels in human polymorphonuclear leukocytes (PMN). Sodium nitroprusside, and the molsidomine (MOL) metabolites SIN-1 and SIN-1A potently inhibited LTB4 release and increased cGMP levels. No significant effects on LTB4 release or cGMP accumulation were observed in the presence of molsidomine or glyceryl trinitrate. None of the compounds tested affected cAMP levels. It is suggested that nitrovasodilators (i) inhibit LTB4 release from human PMN via enhanced cGMP and (ii) that this inhibition requires the presence of an active metabolite, probably nitric oxide.

Original languageEnglish (US)
Pages (from-to)243-245
Number of pages3
JournalEicosanoids
Volume3
Issue number4
StatePublished - 1990

Fingerprint Dive into the research topics of 'Nitrovasodilator-induced inhibition of LTB4 release from human PMN may be mediated by cyclic GMP.'. Together they form a unique fingerprint.

Cite this